USA v. GLENMARK PHARMACEUTICALS, INC., USA

  1. August 21, 2023

    Teva, Glenmark To Pay $305M In Latest DOJ Generics Deal

    The U.S. Department of Justice announced its largest settlement to date Monday in ongoing price-fixing enforcement against major generic-drug companies, with Teva set to pay a $225 million criminal penalty and donate $50 million worth of drugs, while Glenmark plans to pay a $30 million penalty.

  2. December 20, 2022

    Teva, Glenmark Get May 2024 Price-Fixing Criminal Trial

    A Pennsylvania federal judge has set a May 2024 jury trial date for two pharmaceutical companies accused by the U.S. Department of Justice of working together to overcharge for pravastatin, a cholesterol medication, and several other generic drugs.

  3. October 14, 2022

    Teva, Glenmark Won't Get Antitrust Grand Jury Docs

    A Pennsylvania federal judge has denied requests by generic-drug manufacturers Teva Pharmaceuticals USA Inc. and Glenmark Pharmaceuticals Inc. to obtain materials from the grand jury that indicted them for price-fixing.

  4. April 19, 2022

    DOJ Says Teva, Like Glenmark, Can't Get Grand Jury Docs

    Teva, like Glenmark, doesn't have the rights to material from the grand jury that indicted it for price-fixing, the Justice Department told a Pennsylvania federal judge Friday, continuing to argue that grand jury secrecy trumps the companies' "hypothetical concern" that prosecutors could try to expand the allegations against them.

  5. April 04, 2022

    Teva, Like Glenmark, Rips Expanded Price-Fixing Charges

    Teva Pharmaceuticals USA Inc. has told a Pennsylvania federal judge it wants to review the materials prosecutors presented to the grand jury that indicted it on price-fixing charges, arguing the government is trying to accuse it of a conspiracy more expansive than the one charged.

  6. February 16, 2022

    DOJ Pans Glenmark 'Fishing Expedition' For Grand Jury Docs

    Prosecutors asked a Pennsylvania federal judge on Tuesday to reject Glenmark Pharmaceuticals' "fishing expedition" into grand jury materials that led to price-fixing charges against the drugmaker and competitor Teva.

  7. February 02, 2022

    Glenmark Wants Grand Jury Evidence In Price-Fixing Case

    Glenmark Pharmaceuticals has asked a Pennsylvania federal judge to order prosecutors to hand over certain materials from the grand jury that indicted the company and fellow generic-drug maker Teva on price-fixing charges.

  8. January 18, 2022

    Teva, Glenmark Must Face Price-Fixing Suit At Same Trial

    Pharmaceutical companies Glenmark Pharmaceuticals Inc. USA and Teva Pharmaceuticals USA Inc. will have to participate in a dual trial in a lawsuit over price-fixing generic drugs after a Pennsylvania federal judge tossed Glenmark's arguments that trying the cases together would not be fair because Teva has significantly more counts against it in the indictment.

  9. January 13, 2022

    Glenmark's Ethics Allegations Against DOJ Rejected

    A Pennsylvania federal judge has ruled that the U.S. Department of Justice did not breach ethics rules when asking Indian authorities to interview Glenmark executives in its home country for a generic drug price-fixing prosecution, finding prosecutors didn't need to assume the company's U.S. attorneys also represented its parent.

  10. August 24, 2021

    Glenmark Still Fighting To End DOJ Interviews Of India Execs

    Glenmark has asked for a chance to respond to the U.S. Department of Justice's denial of assertions by Teva and Glenmark that the government inappropriately used its Israeli and Indian counterparts to force foreign executives to sit for interviews without going through counsel.